Moderna announces first participant dosed in phase 3 pivotal registration study of its mrna cytomegalovirus (cmv) vaccine

Cambridge, mass.--(business wire)--moderna announces first participant dosed in phase 3 pivotal registration study of its mrna cytomegalovirus (cmv) vaccine

MRNA Ratings Summary

MRNA Quant Ranking